Literature DB >> 14593431

Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype.

N Ozaki1, D Goldman, W H Kaye, K Plotnicov, B D Greenberg, J Lappalainen, G Rudnick, D L Murphy.   

Abstract

Two common serotonin transporter (SERT) untranslated region gene variants have been intensively studied, but remain inconclusively linked to depression and other neuropsychiatric disorders. We now report an uncommon coding region SERT mutation, Ile425Val, in two unrelated families with OCD and other serotonin-related disorders. Six of the seven family members with this mutation had OCD (n=5) or obsessive-compulsive personality disorder (n=1) and some also met diagnostic criteria for multiple other disorders (Asperger's syndrome, social phobia, anorexia nervosa, tic disorder and alcohol and other substance abuse/dependence). The four most clinically affected individuals--the two probands and their two slbs--had the I425V SERT gene gain-of-function mutation and were also homozygous for 5'-UTR SERT gene variant with greater transcriptional efficacy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593431     DOI: 10.1038/sj.mp.4001365

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  91 in total

Review 1.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 2.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Discovery of novel selective serotonin reuptake inhibitors through development of a protein-based pharmacophore.

Authors:  Sankar Manepalli; Laura M Geffert; Christopher K Surratt; Jeffry D Madura
Journal:  J Chem Inf Model       Date:  2011-09-02       Impact factor: 4.956

4.  Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder.

Authors:  R Delorme; C Betancur; M Wagner; M O Krebs; P Gorwood; P Pearl; G Nygren; C M Durand; F Buhtz; P Pickering; J Melke; S Ruhrmann; H Anckarsäter; N Chabane; A Kipman; C Reck; B Millet; I Roy; M C Mouren-Simeoni; W Maier; M Råstam; C Gillberg; M Leboyer; T Bourgeron
Journal:  Mol Psychiatry       Date:  2005-12       Impact factor: 15.992

5.  Myristoylation of cGMP-dependent protein kinase dictates isoform specificity for serotonin transporter regulation.

Authors:  Yuan-Wei Zhang; Gary Rudnick
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

6.  Boron-Doped Diamond Microelectrodes Reveal Reduced Serotonin Uptake Rates in Lymphocytes from Adult Rhesus Monkeys Carrying the Short Allele of the 5-HTTLPR.

Authors:  Yogesh S Singh; Lauren E Sawarynski; Heather M Michael; Robert E Ferrell; Michael A Murphey-Corb; Greg M Swain; Bhavik A Patel; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2010-01-20       Impact factor: 4.418

7.  A competitive inhibitor traps LeuT in an open-to-out conformation.

Authors:  Satinder K Singh; Chayne L Piscitelli; Atsuko Yamashita; Eric Gouaux
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

8.  Enhanced activity of human serotonin transporter variants associated with autism.

Authors:  Harish C Prasad; Jennifer A Steiner; James S Sutcliffe; Randy D Blakely
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

9.  Mice overexpressing the 5-hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine.

Authors:  A Pringle; K A Jennings; S Line; D M Bannerman; S Higgs; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  2008-06-16       Impact factor: 4.530

Review 10.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.